For: | Peta V, Torti C, Milic N, Focà A, Abenavoli L. Adiponectin serum level in chronic hepatitis C infection and therapeutic profile. World J Hepatol 2015; 7(1): 44-52 [PMID: 25624996 DOI: 10.4254/wjh.v7.i1.44] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v7/i1/44.htm |
Number | Citing Articles |
1 |
Yu-Ting Wu, Wan-Yu Huang, Chew-Teng Kor, Ko-Hung Liu, Ting-Yu Chen, Po-Te Lin, Hung-Ming Wu, Martha Asuncion Sánchez-Rodríguez. Relationships between depression and anxiety symptoms and adipocyte-derived proteins in postmenopausal women. PLOS ONE 2021; 16(3): e0248314 doi: 10.1371/journal.pone.0248314
|
2 |
K. Hamdy, R. Al Swaff, H. A. Hussein, M. Gamal. Assessment of serum adiponectin in Egyptian patients with HCV-related cirrhosis and hepatocellular carcinoma. Journal of Endocrinological Investigation 2015; 38(11): 1225 doi: 10.1007/s40618-015-0379-3
|
3 |
Ludovico Abenavoli, Luigi Boccuto. Adiponectin serum level changes and its dynamic relationship with hepatitis C during viral clearance. Virulence 2017; 8(7): 1069 doi: 10.1080/21505594.2017.1315498
|
4 |
娜娜 李. Related Research Progress in Genotyping of Hepatitis C Virus. Advances in Clinical Medicine 2023; 13(05): 7598 doi: 10.12677/ACM.2023.1351061
|
5 |
Raoni Freitas Carvalho, Ajax Mercês Atta, Isabela Silva de Oliveira, Taciana Pereira Sant’Ana Santos, João Pedro A. Santos, Maria Isabel Schinoni, Maria Luiza Brito de Sousa-Atta. Adiponectin levels and insulin resistance among patients with chronic hepatitis C. Acta Tropica 2018; 178: 258 doi: 10.1016/j.actatropica.2017.12.004
|
6 |
Yang Yang, Yue Li, Zhiqiang Ma, Shuai Jiang, Chongxi Fan, Wei Hu, Dongjin Wang, Shouyin Di, Yang Sun, Wei Yi. A brief glimpse at CTRP3 and CTRP9 in lipid metabolism and cardiovascular protection. Progress in Lipid Research 2016; 64: 170 doi: 10.1016/j.plipres.2016.10.001
|
7 |
Teegan R. Lim, Jonathan M. Hazlehurst, Andrei I. Oprescu, Matthew J. Armstrong, Sewa F. Abdullah, Nigel P. Davies, Robert Flintham, Peter Balfe, David J. Mutimer, Jane A. McKeating, Jeremy W. Tomlinson. Hepatitis C virus infection is associated with hepatic and adipose tissue insulin resistance that improves after viral cure. Clinical Endocrinology 2019; 90(3): 440 doi: 10.1111/cen.13924
|
8 |
Chia‐Chi Wang, Pin‐Nan Cheng, Jia‐Horng Kao. Systematic review: chronic viral hepatitis and metabolic derangement. Alimentary Pharmacology & Therapeutics 2020; 51(2): 216 doi: 10.1111/apt.15575
|
9 |
Ester Vanni, Elisabetta Bugianesi, Giorgio Saracco. Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?. Digestive and Liver Disease 2016; 48(2): 105 doi: 10.1016/j.dld.2015.10.016
|
10 |
Ding Liu, Shengyu Li, Zhihong Li. Adiponectin: A biomarker for chronic hepatitis C?. Cytokine 2017; 89: 27 doi: 10.1016/j.cyto.2015.10.016
|
11 |
Chunmei Xu, Junyu Zhao, Xiaojun Zhou, Rui Zhang, Tianyue Xie, Zhiwei Zou, Lin Liao, Jianjun Dong. Thiazolidinediones versus metformin on improving abnormal liver enzymes in patients with type 2 diabetes mellitus: a meta-analysis. Oncotarget 2018; 9(15): 12389 doi: 10.18632/oncotarget.24222
|
12 |
Maja Ružić, Rinaldo Pellicano, Milotka Fabri, Francesco Luzza, Luigi Boccuto, Snežana Brkić, Ludovico Abenavoli. Hepatitis C virus-induced hepatocellular carcinoma: a narrative review. Panminerva Medica 2018; 60(4) doi: 10.23736/S0031-0808.18.03472-9
|
13 |
Ming-Ling Chang, Chia-Jung Kuo, Li-Heng Pao, Chen-Ming Hsu, Cheng-Tang Chiu. The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearance. Virulence 2017; 8(7): 1255 doi: 10.1080/21505594.2017.1300734
|
14 |
Yixiu Zhao, Na Sun, Xia Song, Jia Zhu, Tianshuo Wang, Zhiqi Wang, Yuanyuan Yu, Jing Ren, Huan Chen, Tingting Zhan, Jiaying Tian, Chunyue Ma, Jian Huang, Jinhui Wang, Yan Zhang, Baofeng Yang. A novel small molecule AdipoR2 agonist ameliorates experimental hepatic steatosis in hamsters and mice. Free Radical Biology and Medicine 2023; 203: 69 doi: 10.1016/j.freeradbiomed.2023.04.001
|